Follow
Benjamin Kasenda
Benjamin Kasenda
University Hospital Basel
Verified email at usb.ch
Title
Cited by
Cited by
Year
Prevalence, characteristics, and publication of discontinued randomized trials
B Kasenda, E Von Elm, J You, A Blümle, Y Tomonaga, R Saccilotto, ...
Jama 311 (10), 1045-1052, 2014
3452014
Serum lactate dehydrogenase as an early marker for outcome in patients treated with anti-PD-1 therapy in metastatic melanoma
S Diem, B Kasenda, L Spain, J Martin-Liberal, R Marconcini, M Gore, ...
British journal of cancer 114 (3), 256-261, 2016
3092016
First-line treatment and outcome of elderly patients with primary central nervous system lymphoma (PCNSL)—a systematic review and individual patient data meta-analysis
B Kasenda, AJM Ferreri, E Marturano, D Forst, J Bromberg, ...
Annals of Oncology 26 (7), 1305-1313, 2015
1852015
A systematic review of discontinued trials suggested that most reasons for recruitment failure were preventable
M Briel, KK Olu, E Von Elm, B Kasenda, R Alturki, A Agarwal, N Bhatnagar, ...
Journal of clinical epidemiology 80, 8-15, 2016
1712016
High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study)
K Fritsch, B Kasenda, E Schorb, P Hau, J Bloehdorn, R Möhle, S Loew, ...
Leukemia 31 (4), 846-852, 2017
1512017
High-dose chemotherapy with autologous haemopoietic stem cell transplantation for newly diagnosed primary CNS lymphoma: a prospective, single-arm, phase 2 trial
G Illerhaus, B Kasenda, G Ihorst, G Egerer, M Lamprecht, U Keller, ...
The Lancet Haematology 3 (8), e388-e397, 2016
1502016
Corticosteroids in patients hospitalized with community-acquired pneumonia: systematic review and individual patient data metaanalysis
M Briel, SMC Spoorenberg, D Snijders, A Torres, S Fernandez-Serrano, ...
Clinical Infectious Diseases 66 (3), 346-354, 2018
1332018
Immunochemotherapy with rituximab, methotrexate, procarbazine, and lomustine for primary CNS lymphoma (PCNSL) in the elderly
K Fritsch, B Kasenda, C Hader, G Nikkhah, M Prinz, V Haug, S Haug, ...
Annals of oncology 22 (9), 2080-2085, 2011
1322011
Prognosis after high-dose chemotherapy followed by autologous stem-cell transplantation as first-line treatment in primary CNS lymphoma—a long-term follow-up study
B Kasenda, E Schorb, K Fritsch, J Finke, G Illerhaus
Annals of oncology 23 (10), 2670-2675, 2012
1282012
Meta-analyses: what they can and cannot do
AJ Nordmann, B Kasenda, M Briel
Swiss medical weekly 142 (0910), w13518-w13518, 2012
1192012
Systematic review on costs and resource use of randomized clinical trials shows a lack of transparent and comprehensive data
B Speich, B von Niederhäusern, N Schur, LG Hemkens, T Fürst, ...
Journal of clinical epidemiology 96, 1-11, 2018
1142018
Subgroup analyses in randomised controlled trials: cohort study on trial protocols and journal publications
B Kasenda, S Schandelmaier, X Sun, E Von Elm, J You, A Blümle, ...
Bmj 349, 2014
1082014
Prognosis of patients with primary central nervous system lymphoma after high-dose chemotherapy followed by autologous stem cell transplantation
E Schorb, B Kasenda, J Atta, S Kaun, A Morgner, G Hess, T Elter, ...
haematologica 98 (5), 765, 2013
1022013
Web-based stress management for newly diagnosed patients with cancer (STREAM): a randomized, wait-list controlled intervention study
C Urech, A Grossert, J Alder, S Scherer, B Handschin, B Kasenda, ...
Journal of clinical oncology 36 (8), 780, 2018
932018
High-dose chemotherapy with autologous haematopoietic stem cell support for relapsed or refractory primary CNS lymphoma: a prospective multicentre trial by the German …
B Kasenda, G Ihorst, R Schroers, A Korfel, I Schmidt-Wolf, G Egerer, ...
Leukemia 31 (12), 2623-2629, 2017
842017
Stem cell migration: a quintessential stepping stone to successful therapy
C Weidt, B Niggemann, B Kasenda, TL Drell, KS Zanker, T Dittmar
Current stem cell research & therapy 2 (1), 89-103, 2007
732007
The reporting of studies using routinely collected health data was often insufficient
LG Hemkens, EI Benchimol, SM Langan, M Briel, B Kasenda, JM Januel, ...
Journal of clinical epidemiology 79, 104-111, 2016
722016
Prognostic score for patients with advanced melanoma treated with ipilimumab
S Diem, B Kasenda, J Martin-Liberal, A Lee, D Chauhan, M Gore, J Larkin
European journal of cancer 51 (18), 2785-2791, 2015
692015
High-dose thiotepa-based chemotherapy with autologous stem cell support in elderly patients with primary central nervous system lymphoma: a European retrospective study
E Schorb, CP Fox, K Fritsch, L Isbell, A Neubauer, A Tzalavras, ...
Bone Marrow Transplantation 52 (8), 1113-1119, 2017
682017
High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma—a randomized phase …
E Schorb, J Finke, AJM Ferreri, G Ihorst, K Mikesch, B Kasenda, K Fritsch, ...
BMC cancer 16, 1-9, 2016
672016
The system can't perform the operation now. Try again later.
Articles 1–20